<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://massachusettsweekly.com/article/909711133-wayside-youth-family-support-network-earns-prestigious-2026-usa-today-top-workplaces-award-for-fourth-consecutive-year</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T19:34:45+00:00</news:publication_date>
        <news:title>Wayside Youth &amp; Family Support Network Earns Prestigious 2026 USA TODAY Top Workplaces Award for Fourth Consecutive Year</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909739339-spyre-therapeutics-announces-grants-of-inducement-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:28:07+00:00</news:publication_date>
        <news:title>Spyre Therapeutics Announces Grants of Inducement Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909738988-great-elm-capital-corp-gecc-schedules-first-quarter-2026-earnings-release-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:15:00+00:00</news:publication_date>
        <news:title>Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c67af62e-a4ad-40ad-84f3-30e505895084/small/gecc-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909739233-roblox-investigated-for-securities-fraud-block-leviton-encourages-investors-who-have-lost-money-to-contact-the-firm-to-recover-losses</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:07:15+00:00</news:publication_date>
        <news:title>Roblox Investigated for Securities Fraud; Block &amp; Leviton Encourages Investors Who Have Lost Money to Contact the Firm to Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909738836-solid-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:05:00+00:00</news:publication_date>
        <news:title>Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909738914-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909732252-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:01:00+00:00</news:publication_date>
        <news:title>Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://massachusettsweekly.com/article/909732282-avalyn-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-01T20:01:00+00:00</news:publication_date>
        <news:title>Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
</urlset>
